ArticleCancer medicine2026
Nomogram for Preoperative Prediction of Adjuvant Therapy Requirement Following Radical Surgery in Stage IB Cervical Squamous Cell Carcinoma With Tumor Size ≤ 4 cm: A Retrospective Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to construct a nomogram incorporating preoperative laboratory parameters and clinical pathological factors for the first time to predict the probability of adjuvant therapy requirement following radical surgery in IB stage cervical squamous cell carcinoma (SCC) with tumor size ≤ 4 cm.
methodsClinical pathological parameters and relevant laboratory indicators were collected from IB stage cervical SCC with tumor size ≤ 4 cm patients who underwent radical surgery at our hospital. Patients included in the study were randomly divided into a training set and a validation set in a 7:3 ratio. In the training set, the least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression were used to determine the final variables for constructing the nomogram. Finally, the performance of the nomogram was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) in both the training and validation sets.
resultsThe nomogram ultimately included seven predictive variables. The area under the ROC curve (AUC) for the nomogram in the training and validation sets was 0.863 and 0.767, respectively. Moreover, the calibration curve of the nomogram was relatively close to the ideal curve. The DCA showed that using the nomogram to predict the probability of adjuvant therapy requirement over a wide range of threshold values is beneficial.
conclusionThis study constructed and validated a model for predicting adjuvant therapy requirement in IB stage cervical SCC with tumor size ≤ 4 cm. The model can help clinicians determine the risk of postoperative adjuvant therapy before surgery, promoting personalized treatment choices and patient management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.